Table of Content
Table of Content
1 Recombinant Protein Drug Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Recombinant Protein Drug
1.3 Recombinant Protein Drug Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Recombinant Protein Drug Revenue and Growth Rate from 2018-2030
1.4 Market Segmentation
1.4.1 Types of Recombinant Protein Drug
1.4.2 Applications of Recombinant Protein Drug
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Recombinant Protein Drug Industry Trends
1.5.2 Recombinant Protein Drug Drivers
1.5.3 Recombinant Protein Drug Market Challenges
1.5.4 Recombinant Protein Drug Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Recombinant Protein Drug Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Recombinant Protein Drug Industry Development
2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Recombinant Protein Drug Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Recombinant Protein Drug
2.2.1 Major Players Manufacturing Base of Recombinant Protein Drug in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Recombinant Protein Drug Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Recombinant Protein Drug
2.3.3 Labor Cost of Recombinant Protein Drug
2.4 Market Channel Analysis of Recombinant Protein Drug
2.5 Major Down Stream Customers by Application
3 Global Recombinant Protein Drug Market, by Type
3.1 Global Recombinant Protein Drug Revenue and Market Share by Type (2018-2021)
3.2 Global Recombinant Protein Drug Production and Market Share by Type (2018-2021)
3.3 Global Recombinant Protein Drug Revenue and Growth Rate by Type (2018-2021)
3.3.1 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Insulin
3.3.2 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Interferon (rhIFN)
3.3.3 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Erythropoietin (rhEPO)
3.3.4 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
3.3.5 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Growth Hormone (rhGH)
3.3.6 Global Recombinant Protein Drug Revenue and Growth Rate of Recombinant Human Follicle-stimulating Hormone (rhFSH)
3.3.7 Global Recombinant Protein Drug Revenue and Growth Rate of Others
3.4 Global Recombinant Protein Drug Price Analysis by Type (2018-2021)
3.4.1 Explanation of Different Type Product Price Trends
4 Recombinant Protein Drug Market, by Application
4.1 Downstream Market Overview
4.2 Global Recombinant Protein Drug Consumption and Market Share by Application (2018-2021)
4.3 Global Recombinant Protein Drug Consumption and Growth Rate by Application (2018-2021)
4.3.1 Global Recombinant Protein Drug Consumption and Growth Rate of Hospital use (2018-2021)
4.3.2 Global Recombinant Protein Drug Consumption and Growth Rate of Clinic use (2018-2021)
4.3.3 Global Recombinant Protein Drug Consumption and Growth Rate of Household (2018-2021)
5 Global Recombinant Protein Drug Consumption, Revenue ($) by Region (2018-2021)
5.1 Global Recombinant Protein Drug Revenue and Market Share by Region (2018-2021)
5.2 Global Recombinant Protein Drug Consumption and Market Share by Region (2018-2021)
5.3 Global Recombinant Protein Drug Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4 North America Recombinant Protein Drug Consumption, Revenue, Price and Gross Margin (2018-2021)
5.4.1 North America Recombinant Protein Drug Market Under COVID-19
5.4.2 North America Recombinant Protein Drug SWOT Analysis
5.5 Europe Recombinant Protein Drug Consumption, Revenue, Price and Gross Margin (2018-2021)
5.5.1 Europe Recombinant Protein Drug Market Under COVID-19
5.5.2 Europe Recombinant Protein Drug SWOT Analysis
5.6 China Recombinant Protein Drug Consumption, Revenue, Price and Gross Margin (2018-2021)
5.6.1 China Recombinant Protein Drug Market Under COVID-19
5.6.2 China Recombinant Protein Drug SWOT Analysis
5.7 Japan Recombinant Protein Drug Consumption, Revenue, Price and Gross Margin (2018-2021)
5.7.1 Japan Recombinant Protein Drug Market Under COVID-19
5.7.2 Japan Recombinant Protein Drug SWOT Analysis
5.8 Middle East and Africa Recombinant Protein Drug Consumption, Revenue, Price and Gross Margin (2018-2021)
5.8.1 Middle East and Africa Recombinant Protein Drug Market Under COVID-19
5.8.2 Middle East and Africa Recombinant Protein Drug SWOT Analysis
5.9 India Recombinant Protein Drug Consumption, Revenue, Price and Gross Margin (2018-2021)
5.9.1 India Recombinant Protein Drug Market Under COVID-19
5.9.2 India Recombinant Protein Drug SWOT Analysis
5.10 South America Recombinant Protein Drug Consumption, Revenue, Price and Gross Margin (2018-2021)
5.10.1 South America Recombinant Protein Drug Market Under COVID-19
5.10.2 South America Recombinant Protein Drug SWOT Analysis
5.11 South Korea Recombinant Protein Drug Consumption, Revenue, Price and Gross Margin (2018-2021)
5.11.1 South Korea Recombinant Protein Drug Market Under COVID-19
5.11.2 South Korea Recombinant Protein Drug SWOT Analysis
5.12 Southeast Asia Recombinant Protein Drug Consumption, Revenue, Price and Gross Margin (2018-2021)
5.12.1 Southeast Asia Recombinant Protein Drug Market Under COVID-19
5.12.2 Southeast Asia Recombinant Protein Drug SWOT Analysis
6 Global Recombinant Protein Drug Production by Top Regions (2018-2021)
6.1 Global Recombinant Protein Drug Production by Top Regions (2018-2021)
6.2 North America Recombinant Protein Drug Production and Growth Rate
6.3 Europe Recombinant Protein Drug Production and Growth Rate
6.4 China Recombinant Protein Drug Production and Growth Rate
6.5 Japan Recombinant Protein Drug Production and Growth Rate
6.6 India Recombinant Protein Drug Production and Growth Rate
7 Global Recombinant Protein Drug Consumption by Regions (2018-2021)
7.1 Global Recombinant Protein Drug Consumption by Regions (2018-2021)
7.2 North America Recombinant Protein Drug Consumption and Growth Rate
7.3 Europe Recombinant Protein Drug Consumption and Growth Rate
7.4 China Recombinant Protein Drug Consumption and Growth Rate
7.5 Japan Recombinant Protein Drug Consumption and Growth Rate
7.6 Middle East & Africa Recombinant Protein Drug Consumption and Growth Rate
7.7 India Recombinant Protein Drug Consumption and Growth Rate
7.8 South America Recombinant Protein Drug Consumption and Growth Rate
7.9 South Korea Recombinant Protein Drug Consumption and Growth Rate
7.10 Southeast Asia Recombinant Protein Drug Consumption and Growth Rate
8 Competitive Landscape
8.1 Competitive Profile
8.2 Amgen Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.2.3 Amgen Sales, Revenue, Price, Gross Margin 2018-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Abcam Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.3.3 Abcam Sales, Revenue, Price, Gross Margin 2018-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Merck Serono Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.4.3 Merck Serono Sales, Revenue, Price, Gross Margin 2018-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Kyowa Hakko Kirin Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.5.3 Kyowa Hakko Kirin Sales, Revenue, Price, Gross Margin 2018-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Anhui Anke Biotechnology Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.6.3 Anhui Anke Biotechnology Sales, Revenue, Price, Gross Margin 2018-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Changchun High & New Technology Industry Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.7.3 Changchun High & New Technology Industry Sales, Revenue, Price, Gross Margin 2018-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 GenSci Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.8.3 GenSci Sales, Revenue, Price, Gross Margin 2018-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 NCPC Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.9.3 NCPC Sales, Revenue, Price, Gross Margin 2018-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 SL PHARM Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.10.3 SL PHARM Sales, Revenue, Price, Gross Margin 2018-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Heng Rui Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.11.3 Heng Rui Sales, Revenue, Price, Gross Margin 2018-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Sanofi Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.12.3 Sanofi Sales, Revenue, Price, Gross Margin 2018-2021
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 Ortho Biotech Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.13.3 Ortho Biotech Sales, Revenue, Price, Gross Margin 2018-2021
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19
8.14 Pharmingen Market Performance Analysis
8.14.1 Company Profiles
8.14.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.14.3 Pharmingen Sales, Revenue, Price, Gross Margin 2018-2021
8.14.4 Company Recent Development
8.14.5 Strategies for Company to Deal with the Impact of COVID-19
8.15 Roche Market Performance Analysis
8.15.1 Company Profiles
8.15.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.15.3 Roche Sales, Revenue, Price, Gross Margin 2018-2021
8.15.4 Company Recent Development
8.15.5 Strategies for Company to Deal with the Impact of COVID-19
8.16 Novo Nordisk Market Performance Analysis
8.16.1 Company Profiles
8.16.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.16.3 Novo Nordisk Sales, Revenue, Price, Gross Margin 2018-2021
8.16.4 Company Recent Development
8.16.5 Strategies for Company to Deal with the Impact of COVID-19
8.17 Eli Lilly Market Performance Analysis
8.17.1 Company Profiles
8.17.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.17.3 Eli Lilly Sales, Revenue, Price, Gross Margin 2018-2021
8.17.4 Company Recent Development
8.17.5 Strategies for Company to Deal with the Impact of COVID-19
8.18 Livzon Pharmaceutical Market Performance Analysis
8.18.1 Company Profiles
8.18.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.18.3 Livzon Pharmaceutical Sales, Revenue, Price, Gross Margin 2018-2021
8.18.4 Company Recent Development
8.18.5 Strategies for Company to Deal with the Impact of COVID-19
8.19 Shenzhen Neptunus Interlong Bio-Technique Market Performance Analysis
8.19.1 Company Profiles
8.19.2 Recombinant Protein Drug Product Profiles, Application and Specification
8.19.3 Shenzhen Neptunus Interlong Bio-Technique Sales, Revenue, Price, Gross Margin 2018-2021
8.19.4 Company Recent Development
8.19.5 Strategies for Company to Deal with the Impact of COVID-19
9 Global Recombinant Protein Drug Market Analysis and Forecast by Type and Application
9.1 Global Recombinant Protein Drug Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Recombinant Insulin Market Revenue and Volume Forecast (2021-2026)
9.1.2 Recombinant Human Interferon (rhIFN) Market Revenue and Volume Forecast (2021-2026)
9.1.3 Recombinant Human Erythropoietin (rhEPO) Market Revenue and Volume Forecast (2021-2026)
9.1.4 Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) Market Revenue and Volume Forecast (2021-2026)
9.1.5 Recombinant Human Growth Hormone (rhGH) Market Revenue and Volume Forecast (2021-2026)
9.1.6 Recombinant Human Follicle-stimulating Hormone (rhFSH) Market Revenue and Volume Forecast (2021-2026)
9.1.7 Others Market Revenue and Volume Forecast (2021-2026)
9.2 Global Recombinant Protein Drug Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Hospital use Market Revenue and Volume Forecast (2021-2026)
9.2.2 Clinic use Market Revenue and Volume Forecast (2021-2026)
9.2.3 Household Market Revenue and Volume Forecast (2021-2026)
10 Recombinant Protein Drug Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Recombinant Protein Drug Market Trends Analysis
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
?
